Follow
Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer. (arXiv:2001.10573v1 [q-bio.PE]) http://arxiv.org/abs/2001.10573
Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer. (arXiv:2001.10573v1 [q-bio.PE]) http://arxiv.org/abs/2001.10573